Last reviewed · How we verify
Local standard venous thromboprophylaxis — Competitive Intelligence Brief
phase 3
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Local standard venous thromboprophylaxis (Local standard venous thromboprophylaxis) — UMC Utrecht. Local standard venous thromboprophylaxis prevents blood clots in veins through established anticoagulant or mechanical methods applied according to institutional protocols.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Local standard venous thromboprophylaxis TARGET | Local standard venous thromboprophylaxis | UMC Utrecht | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Local standard venous thromboprophylaxis CI watch — RSS
- Local standard venous thromboprophylaxis CI watch — Atom
- Local standard venous thromboprophylaxis CI watch — JSON
- Local standard venous thromboprophylaxis alone — RSS
Cite this brief
Drug Landscape (2026). Local standard venous thromboprophylaxis — Competitive Intelligence Brief. https://druglandscape.com/ci/local-standard-venous-thromboprophylaxis. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab